Skip to main content
. 2021 May 11;11:10033. doi: 10.1038/s41598-021-89638-x

Table 3.

Univariate analysis: 90-day mortality.

90 day survival 90 day mortality p value
N % Mean SD N % Mean SD
Total patients 568 74.3 196 25.7
Age (y) 65.5 15.3 75.0 14.9  < 0.001
Female 280 49.3 117 59.7 0.012
Race 0.004
White 336 59.2 145 74.0
Black 169 29.8 41 20.9
Asian 10 1.8 2 1.0
Other 52 9.1 8 4.0
Obesity 224 39.4 66 33.7 0.152
Hypertension 409 72.0 163 83.2 0.001
Hyperlipidemia 253 44.5 96 49.0 0.282
Diabetes 151 26.6 56 28.6 0.555
CAD 14 2.5 3 1.5 0.442
Atrial fibrillation 134 23.6 78 39.8  < 0.001
Hx ischemic stroke 121 21.3 48 24.5 0.354
Glucose (mg/dL) 136.4 55.7 149.1 59.2 0.009
NIHSS (median) 12 20
ICA occlusion 139 24.5 63 32.1 0.036
LKW to CS (h) 4.6 5.3 4.9 5.5 0.633
CBF < 30% 450 79.2 19.1 33.9 142 72.4 53.4 70.1  < 0.001
Tm > 6 s 450 79.2 112.4 81.7 142 72.4 162.5 109.4  < 0.001
Any EVT 310 54.6 85 43.4 0.007
Revascularization therapy  < 0.001
No EVT 258 45.4 111 56.6
EVT poor* 30 5.3 24 12.2
EVT good** 280 49.3 61 31.1
D/C mRS (median) 3 5  < 0.001

SD Standard deviation, Hx History, CAD Coronary artery disease, NIHSS National Institute of Health Stroke Scale, ICA Internal carotid artery, LKW Last known well time, CS Code stroke, CBF Cerebral blood flow, Tm > 6 s Time to maximum greater than 6 s, EVT Endovascular therapy, D/C Discharge, mRS Modified Rankin scale score. Percentages listed are with respect to subjects in individual ‘90 day survival’ or ‘90 day mortality’ groups, except for Total Patients.

*EVT poor = EVT with thrombolysis in cerebral infarction score 0–2a.

**EVT good = EVT with thrombolysis in cerebral infarction score 2b–3.